An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s Jose de LeonGeorgios SchoretsanitisChristoph U. Correll Editorial 08 April 2022 Pages: 537 - 540
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies Lucas Silva RodriguesGiordano Novak RossiRafael G. dos Santos Invited Review 29 April 2021 Pages: 541 - 556
Functional and clinical outcomes of FMRI-based neurofeedback training in patients with alcohol dependence: a pilot study Susanne KarchDaniela KrauseDaniel Keeser Original Paper Open access 07 October 2021 Pages: 557 - 569
The German Guidelines for the treatment of anxiety disorders: first revision Borwin BandelowAntonia M. WernerManfred E. Beutel Original Paper Open access 05 October 2021 Pages: 571 - 582
Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study L. MalandainM. LeyguesF. Thibaut Original Paper 22 August 2021 Pages: 583 - 590
Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals TianHong ZhangJunJie WangJiJun Wang Original Paper 18 September 2021 Pages: 591 - 602
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia H. H. StassenS. BachmannE. Seifritz Original Paper Open access 25 November 2021 Pages: 603 - 619
Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the “Parma Early Psychosis” program Lorenzo PelizzaEmanuela LeuciPietro Pellegrini Original Paper 28 January 2022 Pages: 621 - 632
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia Meijuan LiYuying QiuJie Li Original Paper 17 January 2022 Pages: 633 - 642
Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine Peter FalkaiAndrea SchmittMelanie Heitkamp Invited Review Open access 06 December 2021 Pages: 643 - 677
The impact of physical fitness on resilience to modern life stress and the mediating role of general self-efficacy R. J. NeumannK. F. AhrensS. Matura Original Paper Open access 07 October 2021 Pages: 679 - 692
Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling Yunfei TanYuko FujitaKenji Hashimoto Original Paper Open access 03 January 2022 Pages: 693 - 701
Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism Matti GärtnerAnne WeigandSimone Grimm Original Paper Open access 12 January 2022 Pages: 703 - 714
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries Gernot FuggerLucie BartovaSiegfried Kasper Original Paper Open access 06 January 2022 Pages: 715 - 727
The effects of hypnotherapy compared to cognitive behavioral therapy in depression: a NIRS-study using an emotional gait paradigm Alina HaiptDavid RosenbaumAnn-Christine Ehlis Original Paper Open access 03 February 2022 Pages: 729 - 739
The societal cost of treatment-seeking patients with borderline personality disorder in Germany Till WagnerNele AssmannEva Fassbinder Original Paper Open access 04 October 2021 Pages: 741 - 752